Usefulness of bioavailable testosterone assay for the diagnosis of androgen deficiency in elderly males;Intérêt du dosage de testostérone biodisponible pour le diagnostic du déficit androgénique chez l'homme âgé

Annales d'Endocrinologie

Volumn 64, Issue 2, 2003, Pages 117-125

  Lejeune, Hervé ^a,d   Dechaud H ^b   Pugeat, M ^c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c Hopital de l'Antiquaille   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM SULFATE; CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; AGING; ANDROGEN DEFICIENCY; ASSAY; CONFERENCE PAPER; DIAGNOSTIC VALUE; HORMONE ACTION; HORMONE BINDING; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRECIPITATION; SEX HORMONE DETERMINATION; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AGING; ANDROGENS; HUMANS; MALE; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TESTIS; TESTOSTERONE;

EID: 0037988993     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Report of national institute on aging advisory panel on testosterone replacement in men. J Clin Endocrinol Metab 2001; 86: 4611-4.
2. Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men. J Clin Endocrinol Metab 1994; 78: 711-6.
3. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001; 281: E1172-81.
4. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983; 56: 1278-81.
5. Costa P. Adénome prostatique, hormones et androgénothérapie. Andrologie 2002; 12: 133-5.
6. Davidson JM, Chen JJ, Crapo L, Gray GD, Greenleaf WJ, Catania JA. Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab 1983; 57: 71-7.
7. Déchaud H, Lejeune H, Garoscio-Cholet M, Mallein R, Pugeat M. Radioimmunoassay of testosterone not bound to sex-steroid-binding protein in plasma. Clin Chem 1989; 35: 1609-14.
8. Deslypere JP, Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet and activity. J Clin Endocrinol Metab 1984; 59: 955-62.
9. Deslypere JP, Kaufman JM, Vermeulen T, Vogelaers D, Vandalem JL, A. V. Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. J Clin Endocrinol Metab 1987; 64: 68-73.
10. Flam T. Traitement androgénique substitutif et cancer prostatique. Andrologie 2002; 12: 136-7.
11. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73: 1016-25.
12. Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis. J Clin Endocrinol Metab 1997; 82: 3793-6.
13. Harman SM, Tsitouras PD, Costa PT, Blackman MR. Reproductive hormones in aging male. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 1982; 54: 547-51.
14. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86: 724-31.
15. Hayes FJ. Testosterone-fountain of youth or drug of abuse? J Clin Endocrinol Metab 2000; 85: 3020-3.
16. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W. A new 'aging males' symptoms' rating scale. Aging Male 1999; 2: 105-14.
17. Johnson L, Zane R, Petty CS, Neaves WB. Quantification of human Sertoli cell population: its distribution, relation to germ cell number, and age-related decline. Biol Reprod 1984; 31: 785-95.
18. Juul A, Skakkebaek NE. Androgens and the ageing male. Hum Reprod Update 2002; 8: 423-33.
19. Kuhn JM. Déficit androgénique: effet de la substitution sur la composition corporelle. Andrologie 2002; 12: 17-23.
20. Legrand E, Simon V, Audran M. Stéroides sexuels et ostéoporose chez l'homme. Andrologie 2002; 12: 24-31.
21. Legros JJ, Delhez M. Détection de la déficience androgénique chez l'homme de plus de 50 ans: utilisation d'une version française du test ADAM. Med Hyg 2002; 60: 1490-5.
22. Lejeune H. Déficit androgénique lié à l'âge. Andrologie 2001; 11: 231-9.
23. Lejeune H. Le déficit androgénique lié à l'âge chez l'homme: terminologie, épidémiologie. Andrologie 2002; 12: 11-6.
24. Lewis JG, Ghanadian R, Chisholm GD. Serum 5α-dihydrotestosterone and testosterone, changes with age in man. Acta Endocrinol (Copenh) 1976; 82: 444-8.
25. Mahmoud AM, Goemaere S, El-Garem Y, Van Pottelbergh I, Comhaire FH, Kaufman JM. Testicular volume in relation to hormonal indices of gonadal function in community-dwelling elderly men. J Clin Endocrinol Metab 2003; 88: 179-84.
26. Märin P, Krotkiewski M, Björntrop P. Androgen treatment of middle-aged, obese men: effects on metabolism and adipose tissues. Eur J Med 1992; 1: 1329-336.
27. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002; 57: M76-99.
28. Meikle AW, Stanish WM, Taylor N, Edwards C, Bishop DT. Familial effects on plasma sex-steroid content in man: testosterone, estradiol and sex hormone-binding-globulin. Metabolism 1982; 31: 6-9.
29. Mimoun S. Androgènes et qualité de vie. Andrologie 2002; 12: 257-61.
30. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002; 5: 74-86.
31. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000; 49: 1239-42.
32. Muta K, Kato K, Akamine Y, Ibayashi H. Age-related changes in the feedback regulation of gonadotrophin secretion by sex steroids in men.. Acta Endocrinol (Copenh) 1981; 96: 154-62.
33. Neaves WB, Johnson L, Porter JC, Parker CR, Petty CS. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 1984; 59: 756-63.
34. Pardridge WM. Transport of protein-bound hormones into tissues in vivo. Endocr Rev 1981; 2: 103-23.
35. Pirke KM, Doerr P. Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone-binding globulin in normal adult males. Acta Endocrinol (Copenh) 1974; 74: 792-800.
36. Pugeat M, Crave JC, Elmidani M, et al. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol 1991; 40: 841-9.
37. Pugeat MM, Dunn JF, Nisula BC. Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 69-75.
38. Roger M, Lahlou N. Le déficit androgénique lié à l'âge: du diagnostic biologique au traitement substitutif. Andrologie 2002; 12: 138-46.
39. Rosner W. An Extraordinary inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab 2001; 86: 2903.
40. Rubens R, Dhont M, Vermeulen A. Further studies on Leydig cell function in old age. J Clin Endocrinol Metab 1974; 39: 40-5.
41. Seymour FI, Duffy C, Kœrner A. A case of authenticated fertility in a man of 94. JAMA 1935; 105: 1423-4.
42. Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82: 1661-7.
43. Simon D, Preziosi P, Barrett-Connor E, et al. The influence of aging on plasma sex hormone in men: the telecom study. Am J Epidemiol 1992; 135: 783-91.
44. Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf) 2000; 53: 703-11.
45. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966-72.
46. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 2647-53.
47. Snyder PJ, Peachey H, Berlin JA, et al. Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. Am J Med 2001; 111: 255-60.
48. Tenover JS, Dahl KD, Hsueh AJW, Lim P, Matsumoto AM, Bremner WJ. Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men. J Clin Endocrinol Metab 1987; 64: 1103-8.
49. Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol Metab 1987; 65: 1118-26.
50. Tenover JS, McLachlan RI, Dahl KD, Burger HG, De Kretser DM, Bremner WJ. Decreased serum inhibin levels in normal elderly men: evidence for a decline in Sertoli cell function with aging. J Clin Endocrinol Metab 1988; 67: 455-9.
51. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092-8.
52. Tremblay RR, Morales A. Canadian practice recommendations for screening, monitoring aud treating men affected by andropause or partial androgen deficiency. Aging Male 1998; 1: 213-8.
53. Urban RJ, Veldhuis JD, Blizzard RM, Dufau ML. Attenuated release of biologically active luteinizing hormone in healthy aging men. J Clin Invest 1988; 81: 1020-9.
54. Vermeulen A, Rubens R, Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab 1972; 34: 730-5.
55. Vermeulen A, Deslypere JP, Kaufman JM. Influence of antiopioids on luteinizing hormone pulsatility in aging men. J Clin Endocrinol Metab 1989; 68: 68-72.
56. Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996; 81: 1821-6.
57. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-72.
58. Vermeulen A. Androgen replacement therapy in the aging male - a critical evaluation. J Clin Endocrinol Metab 2001; 86: 2380-90.
59. Warner BA, Dufau ML, Santen RJ. Effects of aging and illness on the pituitary testicular axis in men: qualitative as well as quantitative changes in luteinizing hormone. J Clin Endocrinol Metab 1985; 60: 263-8.
60. Winters SJ, Troen P. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol Metab 1982; 55: 560-5.
61. Winters SJ, Sherins RJ, Troen P. The gonadotropin-suppressive activity of androgen is increased in eldrely men. Metabolism 1984; 33: 1052-9.
62. Winters SJ, Kelley DE, Goodpaster B. The analog free testosterone assay: are the results in men clinically useful? Clin Chem 1998; 44: 2178-82.
63. Zumoff B, Strain GW, Kream J, et al. Age variation of the 24-hour mean plasma concentrations of androgens, estrogens and gonadotropins in normal adult men. J Clin Endocrinol Metab 1982; 54: 534-8.